News Archive

EMA

EMA recommends pembrolizumab for the adjuvant treatment of RCC

EMA recommends pembrolizumab for the adjuvant treatment of RCC

EMA| Pembrolizumab

Urologytimes.com reports that the European Medicines Agency’s Committee for Medicinal Products for Human Use ...

EMA Panel Likes Kidney Cancer Drug tivozanib

EMA Panel Likes Kidney Cancer Drug tivozanib

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended ...

EMA recommends two new kidney cancer drugs

EMA recommends two new kidney cancer drugs

Cabozantinib| EMA

Two new drugs for the treatment of adults with advanced kidney cancer are being recommended by the European ...